Evidence map›Paper›PMID 31151321›Full record

ArticleInternational journal of environmental research and public health2019

The Safer Prescription of Opioids Tool (SPOT): A Novel Clinical Decision Support Digital Health Platform for Opioid Conversion in Palliative and End of Life Care-A Single-Centre Pilot Study.

Roger Flint, Deans Buchanan, Scott Jamieson, Alfred Cuschieri, Shady Botros, Joanna Forbes, Jacob George

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A scoping review of rule-based clinical decision support malfunctions.Journal of the American Medical Informatics Association : JAMIA · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roger FlintMedical School, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. rflint@nhs.net.ORCID 0000-0003-0567-0321
Deans BuchananNHS Tayside Ninewells Hospital, Dundee DD1 9SY, UK. deansbuchanan@nhs.net.
Scott JamiesonNHS Tayside Ninewells Hospital, Dundee DD1 9SY, UK. scottjamieson@nhs.net.
Alfred CuschieriMedical School, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. a.cuschieri@dundee.ac.uk.
Shady BotrosNHS Tayside Ninewells Hospital, Dundee DD1 9SY, UK. sbotros@nhs.net.
Joanna ForbesMedical School, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. joanna.forbes@nhs.net.
Jacob GeorgeMedical School, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. J.George@dundee.ac.uk.ORCID 0000-0001-8154-8278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opioid errors are a leading cause of patient harm. Active failures in opioid dose conversion can contribute to error. Conversion is complex and is currently performed manually using tables of approximate equivalence. Apps that offer opioid dose double-checking are available but there are concerns about their accuracy and clinical validation. This study evaluated a novel opioid dose conversion app, The Safer Prescription of Opioids Tool (SPOT), a CE-marked Class I medical device, as a clinician decision support (CDS) platform. This single-centre prospective clinical utility pilot study followed a mixed methods design. Prescribers completed an initial survey exploring their current opioid prescribing practice. Thereafter prescribers used SPOT for opioid dosage conversions in parallel to their usual clinical practice, then evaluated SPOT through a survey and focus group. SPOT matched the Gold Standard result in 258 of 268 (96.3%) calculations. The 10 instances (3.7%) when SPOT did not match were due to a rounding error. Users had a statistically significant increase in confidence in prescribing opioids after using SPOT. Focus group feedback highlighted benefits in Quality Improvement and Safety when using SPOT. SPOT is a safe, reliable and validated CDS that has potential to reduce harms from opioid dosing errors.

Indexed as

Analgesics, OpioidDecision Support Systems, ClinicalDose-Response Relationship, DrugHumansMobile ApplicationsPalliative CarePilot ProjectsPractice Patterns, Physicians'Prospective StudiesTerminal CareAnalgesics, OpioidClinical Decision Support SystemsFocus GroupsOpioid AnalgesicsPalliative CarePilot Projects

Identifiers

PMID31151321
PMCPMC6612362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.